Form 4: P3 Health Partners Director Acquires Stock Options

Lawrence B. Leisure, a director of P3 Health Partners Inc., acquired stock options for 482,640 shares of Class A Common Stock on June 6, 2024.

Summary

• On June 6, 2024, Lawrence B. Leisure, a director of P3 Health Partners Inc. (PIII), acquired stock options for 482,640 shares of Class A Common Stock.
• The options have an exercise price of $0.5461.
• The options vest on the earlier of June 6, 2025, or the date of the next annual meeting of the Issuer's stockholders, contingent upon continued service.
• Following the transaction, Leisure directly owns options for 482,640 shares.
• A Power of Attorney was executed in July 2021, granting Aric Coffman, Leslie Fisher, and Atul Kavthekar the authority to act on Leisure's behalf for SEC filings related to P3 Health Partners Inc.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting a transaction. The sentiment is slightly positive as it indicates a director's increased stake in the company, suggesting confidence, but it's a routine filing.

Positives

• The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance beyond the vesting schedule of the options.

Industry Context

This filing is a routine disclosure related to insider transactions, common in publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders, which is important for investor confidence.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation in the healthcare industry, used to align management's interests with those of shareholders.
• The vesting schedule and exercise price are typical for such grants, often tied to continued employment and market conditions.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a company director.

Key Dates